Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
PCSK9 inhibitors and ACS

PCSK9 inhibitors and ACS

T1DM Mini-Series: How to Avoid Hypoglycaemia in People with T1 Diabetes?

T1DM Mini-Series: How to Avoid Hypoglycaemia in People with T1 Diabetes?

How does Dupixent support lung function improvement in Pediatric Asthma?

How does Dupixent support lung function improvement in Pediatric Asthma?

No Rebound Effect Post Clopidogrel Withdrawal

No Rebound Effect Post Clopidogrel Withdrawal

Insights and impacts from the TALOS-AMI Trial

Insights and impacts from the TALOS-AMI Trial

How does Dupixent improve Asthma control and quality of live for Pediatric Patients?

How does Dupixent improve Asthma control and quality of live for Pediatric Patients?

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

Statin/ezetimibe SPC for better adherence to LLT

Statin/ezetimibe SPC for better adherence to LLT

The reason for MS – beyond focal inflammation

The reason for MS – beyond focal inflammation

There is significant unmet need in the management of PN¹

There is significant unmet need in the management of PN¹

Statin/Ezetimibe Combination VS Statin Monotherapy

Statin/Ezetimibe Combination VS Statin Monotherapy

Single-Pill Combinations in Dyslipidemia

Single-Pill Combinations in Dyslipidemia

This review describes the potential benefits of combination treatment and presents data supporting the use of single-pill combination (SPC) for increasing exposure to lipid-lowering treatment (LLT).